Abstract
Indoramin, an alpha-adrenoceptor blocking drug, has been found to prevent the occurrence of exercise-induced bronchoconstriction. Evidence is provided in two cases that this was not due to the antihistamine properties of indoramin.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Birmingham A. T., Szolcsányi J. Competitive blockade of adrenergic alpha-receptors and histamine receptors by thymoxamine. J Pharm Pharmacol. 1965 Jul;17(7):449–458. doi: 10.1111/j.2042-7158.1965.tb07701.x. [DOI] [PubMed] [Google Scholar]
- GRAY I., BEETHAM W. P., Jr Changes in plasma concentration of epinephrine and norepinephrine with muscular work. Proc Soc Exp Biol Med. 1957 Dec;96(3):636–638. doi: 10.3181/00379727-96-23561. [DOI] [PubMed] [Google Scholar]
- Lewis P. J., George C. F., Dollery C. T. Clinical evaluation of indoramin, a new antihypertensive agent. Eur J Clin Pharmacol. 1973 Dec;6(4):211–216. doi: 10.1007/BF00644733. [DOI] [PubMed] [Google Scholar]
- Royds R. B., Coltart D. J., Lockhart J. D. Pharmacologic studies of indoramin in man. Clin Pharmacol Ther. 1972 May-Jun;13(3):380–392. doi: 10.1002/cpt1972133380. [DOI] [PubMed] [Google Scholar]